-
Xavier Núñez joins the new emerging pan-European CRO as Chief Operating Officer, bringing his extensive experience and track record in the field of clinical research.
Madrid, 5 June, 2023.
Henko Partners, an Iberian private equity firm, is pleased to announce that Xavier Núñez has joined the new pan-European start-up CRO comprising BioClever, Popsicube and MissionTec as Chief Operating Officer (COO). Xavier Núñez has been incorporated as Chief Operating Officer (COO) to the new emerging pan-European CRO comprising BioClever, Popsicube and MissionTec.
Xavier has over 23 years of experience in clinical development and has been an operations leader in mid-sized CROs for the last 9 years. He has focused on biometric services and has demonstrated successful management of teams in the EU, US and Asia.
Ongoing integration and further expansion across Europe are progressing rapidly following the acquisition of the CROs BioClever (Spain), Popsicube and MissionTec (both in France). All this with the aim of establishing a complete, high-quality, customer-oriented, full-service portfolio company serving research and clinical development in the pharmaceutical, biotech, medical device and cellular biotechnology sectors.
"I feel very privileged to join this fantastic new project," he said. Xavi Núñez. "The current and future CROs that will form the new European CRO bring the right culture, talent and passion to continue to deliver the best services to our clients. Our integration is focused on maintaining the quality of our local services while building a strong international team harmonised with outstanding talent from different organisations. Quality, dedication to deadlines and team spirit are our foundation; our customers and clinical trial participants remain our priority.
"We welcome Xavi on board," he adds. Lars BeckerHenko's partner. "He brings a wealth of experience to our European CRO and will help us shape this new venture. His focus on excellence, but also on people and culture, will accelerate our path towards providing outstanding clinical trial services on a European level".
About BioClever:
BioClever is a Spanish CRO offering a global research service, from project design to publication of results. Services cover design, execution, monitoring and customised management of clinical trials and observational studies. Based in Barcelona, and founded in 2005 by Jordi Cantoni and Mireia Bonet, BioClever has a portfolio of first-rate clients and credentials and publications in clinical research of reference in Spain in recent years.
About PopsiCube:
PopsiCube is a France-based contract research organisation (CRO) offering comprehensive clinical trial services. The company has nearly 20 years of experience in providing efficient and cost-effective clinical research services to clients in the pharmaceutical, biotech and medical device industries. PopsiCube's team of experts provides study design, site selection, regulatory affairs, project management, monitoring and data management services.
About MissionTEC:
MissionTEC is a leading clinical research organisation specialising in the provision of clinical research nursing services and support to research sites. The company has a strong presence in Europe, with an extensive network of experienced and highly trained clinical research nurses providing innovative solutions for clinical research studies. MissionTEC's services include, among others, home health care services, patient recruitment and retention support, study drug administration or sample collection.
About Henko Capital Partners:
Henko Capital Partners is an independent private equity firm focused on supporting Spanish and Portuguese SMEs in markets with long-term growth trends. The strategy is to work with entrepreneurs and management teams to develop high potential businesses. In partnership with companies, the firm drives strategic initiatives and practical operational improvements. As entrepreneurs for entrepreneurs, the firm supports companies to accelerate their growth and transform themselves into more resilient and sustainable businesses. Our team has extensive investment experience and a strong track record of execution with over 30 closed transactions in business services, manufacturing, technology, telecommunications and healthcare. Henko Partners is a responsible investor committed to strict environmental, social and governance principles.
